India Silent Heart Attack Market to Reach $433.7 Million by 2035

Indian silent heart attack market was valued at $$188.6 million in 2025 and is projected to reach $433.7 million by 2035, growing at a CAGR of 8.7% during the forecast period (2026–2035). Market growth is driven by the increasing burden of cardiovascular diseases and the rising demand for early diagnostic technologies. According to the World Health Organization (WHO), cardiovascular diseases account for nearly 19.8 million deaths annually, representing approximately 32% of global mortality. India bears a significant share of this burden, with rising cases of hypertension, diabetes, and sedentary lifestyles increasing the risk of silent myocardial infarction. This growing prevalence is accelerating the adoption of ECG systems, cardiac biomarker testing, and advanced imaging solutions across hospitals, diagnostic centers, and home care settings in India.

Browse the full report description of “India Silent Heart Attack Market Size, Share & Trends Analysis Report by Diagnostic (Electrocardiogram (ECG), Cardiac Biomarkers Testing, Cardiac Imaging, Wearable & Remote Monitoring Devices), by Treatment Type (Pharmacological Treatment, Interventional Procedures, Lifestyle & Preventive Management), by End-User (Hospitals, Cardiology Clinics, Diagnostic Centers, Homecare Settings), and Forecast Period (2026–2035)” at https://www.omrglobal.com/industry-reports/india-silent-heart-attack-market

In India, wearable & remote monitoring devices are witnessing significant growth in the silent heart attack market due to the increasing prevalence of cardiovascular diseases, rising health awareness, and growing adoption of digital healthcare technologies. Consumers are increasingly using smartwatches, portable ECG monitors, and AI-enabled cardiac tracking systems for continuous heart monitoring and early detection of asymptomatic cardiac conditions. The expansion of telemedicine services, improving smartphone penetration, and government initiatives supporting digital health infrastructure are further driving segment growth. In addition, the rising preference for preventive healthcare and home-based patient monitoring is encouraging the adoption of remote cardiac monitoring solutions across both urban and semi-urban regions. Healthcare technology companies are also introducing affordable and user-friendly wearable devices to improve accessibility among high-risk populations. These advancements are supporting early diagnosis, timely medical intervention, and better management of silent heart attack risks in India.

Competitive Landscape of the Indian Silent Heart Attack Market

The key players in the Indian silent heart attack market include top companies such as Abbott Laboratories, Medtronic, Siemens Healthineers, Danaher, and Philips Healthcare, among others. The market is witnessing strong growth due to increasing awareness of asymptomatic cardiac conditions and rising use of wearable ECG devices, high-sensitivity troponin testing, and AI-enabled imaging systems. Hospitals and diagnostic centers are enhancing screening capabilities to detect silent cardiac events early, improving clinical outcomes and reducing long-term complications.

• In February 2026, researchers and clinicians in Tamil Nadu initiated trials of an AI-powered mobile ECG tool capable of identifying silent heart attacks (unrecognized myocardial infarction) using electrocardiogram signals integrated with artificial intelligence. The initiative highlights the growing adoption of AI-assisted screening technologies in India for detecting asymptomatic cardiac events in underserved populations.

• In November 2025, Indian med-tech company Sunfox Technologies received national recognition for its Spandan AI-ECG platform, a portable cardiac diagnostic device increasingly deployed for rapid heart-health screening and early detection of cardiac abnormalities. The company’s expansion of AI-enabled ECG diagnostics contributes to the broader accessibility of early heart attack and silent cardiac event detection in India.

 Market Coverage

• The market number available for – 2025–2035
• Base year- 2025
• Forecast period- 2026–2035
• Segment Covered-
• By Diagnostic
• By Treatment Type
• By End User
• Competitive Landscape: Abbott Laboratories, Medtronic, Siemens Healthineers, Danaher, and Philips Healthcare, among others.

 Key questions addressed by the report

• What is the market growth rate?
• Which segment and region dominate the market in the base year?
• Which segment and region will project the fastest growth in the market?
• Who is the leader in the market?
• How are players addressing challenges to sustain growth?
• Where is the investment opportunity?

 India Silent Heart Attack Market Report Segment

By Diagnostic

• Electrocardiogram (ECG)
• Cardiac Biomarkers Testing (Troponin, CK-MB)
• Cardiac Imaging
• Wearable & Remote Monitoring Devices

By Treatment Type

• Pharmacological Treatment
• Interventional Procedures
• Lifestyle & Preventive Management

By End User

• Hospitals
• Cardiology Clinics
• Diagnostic Centers
• Homecare Settings

To learn more about this report request a sample copy @ https://www.omrglobal.com/request-sample/india-silent-heart-attack-market